vp-157 vs bpc-157 For Knee Pain: Early Reported Outcomes, A report on intra-articular BPC-157 for knee pain described high rates of improvement: ~92% with BPC-157 alone, ~75% when combined with thymosin beta-4, Peptide BPC-157 - Does It

The tissue was mechanically minced with sterile scissors and enzymatically digested in collagenase type I solution (0.1 mg/mL) (SCR103, Merck Millipore, Darmstadt, Germany) for 40 min in a CO incubator (37 C, 5% CO2 and 95% humidity) (BINDER GmbH, CBF170, Tuttlingen, Germany)

American Family Physician, 96(6), 384-388

A 2024 systematic review covering 36 studies found BPC-157 improved outcomes across muscle, tendon, ligament, and bone injury models with 7 of 12 people reporting chronic pain relief lasting more than six months after a single treatment

People in generally good health, without serious medical conditions such as uncontrolled diabetes, liver disease, or allergies to any ingredients in the injection, may be considered for skinny shots

Ask your doctor for more information